Purpose: Constipation is a common complication of diabetic patients, which has a negative impact on their own health. This study aims to establish and internally validate the risk nomogram of constipation in patients with type 2 diabetes mellitus (T2DM) and to test its predictive ability.
Patients And Methods: This retrospective study included 746 patients with T2DM at two medical centers.
Background: Gastric cancer (GC) has been divided into four molecular subtypes, of which the mesenchymal subtype has the poorest survival. Our goal is to develop a prognostic signature by integrating the immune system and molecular modalities involved in the mesenchymal subtype.
Methods: The gene expression profiles collected from 6 public datasets were applied to this study, including 1,221 samples totally.